Apex Ascension – Healthcare Capital Raising Firm

Premier Healthcare Capital Raising Firm

Connecting high-growth companies with the right healthcare investors.

To deliver superior results, we onboard a maximum of 8 strategic partners per quarter.

Our Mission

We help healthcare companies eliminate months of fundraising hurdles by connecting them with aligned institutional investors and strategic partners—by ticket size, interest and deep industry expertise—within 21 days. Our partners and strategic advisors have raised $250M in healthcare.

Aggregated Transactions

$ 0 B

Raised In Healthcare

0 M

Years Capital Markets Experience

0 +

Healthcare Investors Introduction Made

0 +

Connecting With The Best In Healthcare

Don't Take Our Word For It

“After three months with another firm and no VC meetings, we were frustrated by the misalignment in investor fit. Apex Ascension changed everything. In just more than a week, they secured 14 meetings with perfectly aligned investors in terms of ticket size and interest. “

Nandan Rao

CEO, Kannact Health & Starlight

“Raising funds for our digital health company has always been challenging, particularly getting in front of investors. This time, we partnered with Nam and his team at Apex Ascension, and the results have been outstanding. “

Dr Michael J. Gardner

Founder, National Scoliosis Clinic

“Apex Ascension has introduced us to a lot of investors, and they’ve done a great job for us.”

Thomas Kinder

CEO, Subchondral Solutions

Before working with you, I tried multiple firms that took retainers but produced no results. You’re the only one who set us up with quality meetings, leading to 17 investor calls and several NDAs. I appreciate your energy and proactive approach—you’re hungry and driven, which sets you apart. I would give you the highest recommendation.

Jack J. Illare III

Founder of Ontheline

Before, we worked with investment bankers who provided a list of 100 contacts but nothing happened. Within a short time working with Apex, we had close to 20 aligned investor meetings. Their filtering process ensures we meet with the right people, making a real difference

Ron Nagar

Founder of Tempramed

Investor Verticals We Work With

Institutional Investors

These are sophisticated entities such as banks, insurance firms, and pension funds, characterized by their substantial capital base and rigorous investment protocols. Institutional investors prioritize stable, long-term returns and typically engage in diversified investment portfolios.

Accredited Retail

High Net Worth Individuals (HNWI)/Angels

HNWIs, distinguished by their considerable wealth, actively engage in direct investments, particularly in nascent ventures, as angel investors. Apart from financial backing, they offer valuable expertise, networks, and mentorship. HNWIs and angels seek opportunities that align with their risk appetite and strategic interests.

Dive Deeper Into Our Healthcare Capital Raising Process

01 Solving For Investor Segment

Using proprietary technology and extensive networks, we identify and segment investors based on investment stage, valuation, and industry specialization. This approach ensures a curated list of mandate-specific investors tailored to healthcare companies, including medtech, biotech, and health IT.

Our precise targeting enhances outreach effectiveness and secures strong investor commitments.

02 Solving For Presentation

In Phase 2, we develop and refine all marketing materials, including presentation decks and video presentations, to effectively communicate the value proposition to investors.

We focus on concise messaging, visual aids, and storytelling techniques to enhance engagement and understanding.

Utilizing online channels for distribution amplifies visibility and reach, ensuring that healthcare companies connect with the right investors.

03 Solving Introductions

Phase 3 focuses on leveraging existing networks and strategic outreach to connect with potential investors. This includes private server email campaigns, personalized outreach, and content optimization.

We also expand reach through Linkedin campaigns and targeted outreach to ensure engagement with relevant investors, maximizing opportunities for successful connections.

04 Solving For Conversions

Phase 4 emphasizes building on introductions by conducting pre-meeting due diligence on investors, assigning an analyst to introductory calls, and refining materials and communication based on prospect feedback and initial conversations.

This ensures a tailored approach, maximizing the potential for successful engagement and progression toward investment agreements.

05 Solving For Deal Closure

Phase 5 focuses on deal closure by establishing a comprehensive data room, minimizing hold-ups during due diligence, and expediting the overall process.

Our attention to detail ensures completeness and accessibility of documentation, addressing investor concerns preemptively to facilitate a smooth and efficient closure.

Meet Our Distinguished Team

Book Your Call Today

Unlock Innovative Access to Global Capital with Direct Channels to Over 10 Million Institutional, Accredited Retail, and Angel Investors

Apply

Premier Healthcare Capital Raising Firm

Our Mission

Connecting With The Best In Healthcare